International journal of obstetric anesthesia · 2025
Nitrous oxide in labor and neonatal hyperbilirubinemia: a retrospective propensity score-matched study (2012-2023).
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Racman P Vovk, Pintaric T Stopar, Verdenik I, Lucovnik M
Аннотация
BACKGROUND: We aimed to evaluate the association between intrapartum nitrous oxide analgesia and neonatal hyperbilirubinemia compared with other analgesic methods, and to assess additional short-term neonatal outcomes.
METHODS: This retrospective epopulation-based, retrospective propensity score-matched cohort study used data from the Slovenian National Perinatal Database. Singleton pregnancies at ≥35 weeks' gestation from 2012 to 2023 were included. Cases with intrapartum nitrous oxide analgesia, remifentanil, pethidine, or neuraxial analgesia were matched 1:1:1:1 based on maternal age, parity, body-mass-index, socioeconomic status, smoking, gestational age, and labor duration. The primary outcome was neonatal hyperbilirubinemia. Secondary outcomes included neonatal intensive care unit (NICU) admission, Apgar scores <7 at 1 and 5 min, neonatal hypoglycemia, and a composite of respiratory morbidity. Outcomes were compared using chi-square tests with Bonferroni-corrected pairwise comparisons.
RESULTS: The study included 32,744 births (8,186 per group). Neonatal hyperbilirubinemia rate was 13.5% with nitrous oxide exposure, 14.9% with remifentanil, 15.8% with pethidine, and 14.2% with neuraxial analgesia (P = 0.0003). Hyperbilirubinemia rate was significantly higher after pethidine exposure compared with nitrous oxide (P = 0.0002) however NICU admission was more common after nitrous oxide exposure (n = 244; P < 0.001). Pethidine exposure was associated with more frequent Apgar <7 at 1 min (n = 245; P < 0.001), and remifentanil was associated with more frequent neonatal hypoglycemia (n = 222; P < 0.001). There were no significant differences in Apgar <7 at 5 min or respiratory morbidity between exposures.
CONCLUSIONS: Intrapartum nitrous oxide analgesia was not associated with increased neonatal hyperbilirubinemia compared with other labor analgesic modalities. However, the NICU admission rate after nitrous oxide exposure was significantly higher.
METHODS: This retrospective epopulation-based, retrospective propensity score-matched cohort study used data from the Slovenian National Perinatal Database. Singleton pregnancies at ≥35 weeks' gestation from 2012 to 2023 were included. Cases with intrapartum nitrous oxide analgesia, remifentanil, pethidine, or neuraxial analgesia were matched 1:1:1:1 based on maternal age, parity, body-mass-index, socioeconomic status, smoking, gestational age, and labor duration. The primary outcome was neonatal hyperbilirubinemia. Secondary outcomes included neonatal intensive care unit (NICU) admission, Apgar scores <7 at 1 and 5 min, neonatal hypoglycemia, and a composite of respiratory morbidity. Outcomes were compared using chi-square tests with Bonferroni-corrected pairwise comparisons.
RESULTS: The study included 32,744 births (8,186 per group). Neonatal hyperbilirubinemia rate was 13.5% with nitrous oxide exposure, 14.9% with remifentanil, 15.8% with pethidine, and 14.2% with neuraxial analgesia (P = 0.0003). Hyperbilirubinemia rate was significantly higher after pethidine exposure compared with nitrous oxide (P = 0.0002) however NICU admission was more common after nitrous oxide exposure (n = 244; P < 0.001). Pethidine exposure was associated with more frequent Apgar <7 at 1 min (n = 245; P < 0.001), and remifentanil was associated with more frequent neonatal hypoglycemia (n = 222; P < 0.001). There were no significant differences in Apgar <7 at 5 min or respiratory morbidity between exposures.
CONCLUSIONS: Intrapartum nitrous oxide analgesia was not associated with increased neonatal hyperbilirubinemia compared with other labor analgesic modalities. However, the NICU admission rate after nitrous oxide exposure was significantly higher.